Kemper (NYSE:KMPR) Price Target Raised to $84.00

Kemper (NYSE:KMPR) had its target price lifted by stock analysts at TD Cowen from $72.00 to $84.00 in a report issued on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the insurance provider’s stock. TD Cowen’s price target would suggest a potential upside of 19.66% from the stock’s previous close.

Other equities research analysts have also recently issued reports about the company. JMP Securities reissued a “market outperform” rating and set a $85.00 price objective on shares of Kemper in a research note on Tuesday, October 15th. Piper Sandler increased their price target on Kemper from $77.00 to $80.00 and gave the company an “overweight” rating in a report on Tuesday, August 6th. StockNews.com raised shares of Kemper from a “hold” rating to a “buy” rating in a research note on Monday, November 4th. Raymond James increased their target price on shares of Kemper from $70.00 to $75.00 and gave the company a “strong-buy” rating in a research note on Thursday, August 8th. Finally, UBS Group lifted their price target on shares of Kemper from $67.00 to $71.00 and gave the stock a “buy” rating in a research note on Tuesday, August 13th. Five investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $79.00.

Kemper Stock Performance

NYSE KMPR traded down $0.33 on Tuesday, hitting $70.20. 37,871 shares of the company traded hands, compared to its average volume of 374,738. The company has a current ratio of 0.22, a quick ratio of 0.22 and a debt-to-equity ratio of 0.50. Kemper has a 52-week low of $40.93 and a 52-week high of $71.57. The business’s 50 day moving average price is $62.90 and its 200-day moving average price is $61.41. The company has a market capitalization of $4.50 billion, a price-to-earnings ratio of 16.71 and a beta of 0.85.

Kemper (NYSE:KMPR) last announced its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $1.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.34 by $0.28. Kemper had a net margin of 5.86% and a return on equity of 12.03%. The business had revenue of $1.18 billion during the quarter, compared to analyst estimates of $1.07 billion. During the same period last year, the firm posted ($0.44) EPS. The company’s revenue was down 1.7% on a year-over-year basis. Equities analysts expect that Kemper will post 5.17 earnings per share for the current year.

Hedge Funds Weigh In On Kemper

Institutional investors have recently modified their holdings of the stock. GAMMA Investing LLC grew its position in shares of Kemper by 114.7% during the 3rd quarter. GAMMA Investing LLC now owns 541 shares of the insurance provider’s stock worth $33,000 after buying an additional 289 shares in the last quarter. Allspring Global Investments Holdings LLC grew its holdings in Kemper by 5,590.0% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 569 shares of the insurance provider’s stock worth $35,000 after acquiring an additional 559 shares in the last quarter. LRI Investments LLC purchased a new position in Kemper during the 1st quarter valued at about $36,000. Quarry LP increased its position in Kemper by 105.1% during the 2nd quarter. Quarry LP now owns 642 shares of the insurance provider’s stock valued at $38,000 after purchasing an additional 329 shares during the period. Finally, Capital Performance Advisors LLP bought a new stake in shares of Kemper in the 3rd quarter valued at about $46,000. 86.23% of the stock is owned by hedge funds and other institutional investors.

About Kemper

Kemper Corporation, a diversified insurance holding company, engages in the provision of insurance products to individuals and businesses in the United States. The company operates through three segments: Specialty Property & Casualty Insurance, Preferred Property & Casualty Insurance, and Life & Health Insurance.